A ketogenic diet attenuates proliferation and stemness of glioma stem‑like cells by altering metabolism resulting in increased ROS production-Reference-Cited by-同舟云学术

A ketogenic diet attenuates proliferation and stemness of glioma stem‑like cells by altering metabolism resulting in increased ROS production

Published:2019-12-13 Issue: Volume: Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Ji Chen‑Chen¹,Hu Yi‑Yang²,Cheng Guang¹,Liang Liang²,Gao Bo³,Ren Ying‑Peng¹,Liu Jin‑Tao⁴,Cao Xiu‑Li²,Zheng Min‑Hua²,Li San‑Zhong¹,Wan Feng⁵,Han Hua¹,Fei Zhou¹

Affiliation:

1. Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China

2. State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China

3. Department of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China

4. Department of Orthopedic Surgery, 413 Hospital, Zhoushan, Zhejiang 316000, P.R. China

5. Department of Neurosurgery, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current advances in cancer energy metabolism under dietary restriction: a mini review;Medical Oncology;2024-07-26

2. Metabolic alterations and cellular responses to β-Hydroxybutyrate treatment in breast cancer cells;Cancer & Metabolism;2024-05-29

3. Beta hydroxybutyrate induces lung cancer cell death, mitochondrial impairment and oxidative stress in a long term glucose-restricted condition;Molecular Biology Reports;2024-04-24

4. β-hydroxybutyrate inhibits malignant phenotypes of prostate cancer cells through β-hydroxybutyrylation of indoleacetamide-N-methyltransferase;Cancer Cell International;2024-03-30

5. Improved therapy for clear cell renal cell carcinoma: beta-hydroxybutyrate and quercetin target hypoxia-induced angiogenesis and multidrug resistance;Molecular Biology Reports;2024-03-02